Primary palliative care for heart failure provided within ambulatory cardiology: A randomized pilot trial.
Dio Kavalieratos, Matthew E Harinstein, Beth Rose and 9 others
PMID 35863099WHAT IT FOUND
A nurse-led palliative care program for heart failure was feasible in routine cardiology visits.
Patients found it acceptable, but the pilot did not compare outcomes with usual care, so it does not show the program improves symptoms or quality of life.
Key findings
01The pilot consented 30 patients over 78 weeks, with 20 randomized to the intervention and 10 to usual care.
02The first intervention visit lasted a mean 46 minutes, visits 2-4 lasted a mean 31.82 minutes, and mean fidelity was 80.6%.
03Among 16 intervention participants who completed at least one survey, 15 agreed or strongly agreed they were satisfied with their care.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The trial was done at one community cardiology clinic with one nurse, so it may not reflect other clinics or staffing models. It randomized only 30 patients and did not compare outcomes between the intervention and usual care groups. Attrition was high: 40% in the intervention group and 50% in the control group. Mortality was 17% of randomized participants, which may affect how well the intervention could be completed. Most participants were white (83%), so the findings may not apply to all patient groups. Qualitative interviews included only 4 intervention participants, one nurse, and one cardiologist. The study paid for the nurse's time and resources, which may not be available in usual clinical practice.
Declared interests
The work was supported by the National Heart Lung and Blood Institute. Authors declared funding grants from the Cystic Fibrosis Foundation, American Heart Association, National Institutes of Health, and Patient-Centered Outcomes Research Institute. Larry Allen reported consulting or advisory work for Boston Scientific Corp.
The easy way to misread this
Do not read 93.75% satisfaction or 87.5% agreement that all patients should receive the intervention as proof that the program improves heart failure outcomes. The study did not test differences between intervention and usual care, and the authors say pilot results should not be used to drive clinical care decisions until powered trials show efficacy.